Department of Critical Care Medicine and Libin Cardiovascular Institute, University of Calgary and Alberta Health Services, ICU Administration - Ground Floor - McCaig Tower, Foothills Medical Center, 3134 Hospital Drive NW, Calgary, AB, T2N 5A1, Canada.
Department of Medicine and Libin Cardiovascular Institute, University of Calgary and Alberta Health Services, Calgary, AB, Canada.
Can J Anaesth. 2021 Jan;68(1):64-70. doi: 10.1007/s12630-020-01787-1. Epub 2020 Aug 14.
Prone positioning of non-intubated patients with coronavirus disease (COVID-19) and hypoxemic respiratory failure may prevent intubation and improve outcomes. Nevertheless, there are limited data on its feasibility, safety, and physiologic effects. The objective of our study was to assess the tolerability and safety of awake prone positioning in COVID-19 patients with hypoxemic respiratory failure.
This historical cohort study was performed across four hospitals in Calgary, Canada. Included patients had suspected COVID-19 and hypoxic respiratory failure requiring intensive care unit (ICU) consultation, and underwent awake prone positioning. The duration, frequency, tolerability, and adverse events from prone positioning were recorded. Respiratory parameters were assessed before, during, and after prone positioning. The primary outcome was the tolerability and safety of prone positioning.
Seventeen patients (n = 12 ICU, n = 5 hospital ward) were included between April and May 2020. The median (range) number of prone positioning days was 1 (1-7) and the median number of sessions was 2 (1-6) per day. The duration of prone positioning was 75 (30-480) min, and the peripheral oxygen saturation was 91% (84-95) supine and 98% (92-100) prone. Limitations to prone position duration were pain/general discomfort (47%) and delirium (6%); 47% of patients had no limitations. Seven patients (41%) required intubation and two patients (12%) died.
In a small sample, prone positioning non-intubated COVID-19 patients with severe hypoxemia was safe; however, many patients did not tolerate prolonged durations. Although patients had improved oxygenation and respiratory rate in the prone position, many still required intubation. Future studies are required to determine methods to improve the tolerability of awake prone positioning and whether there is an impact on clinical outcomes.
对患有冠状病毒病(COVID-19)和低氧性呼吸衰竭的非插管患者进行俯卧位可能会预防插管并改善预后。然而,有关其可行性、安全性和生理影响的数据有限。我们的研究目的是评估 COVID-19 低氧性呼吸衰竭患者清醒俯卧位的耐受性和安全性。
这是一项在加拿大卡尔加里的 4 家医院进行的历史性队列研究。纳入的患者疑似患有 COVID-19,且存在需要 ICU 会诊的低氧性呼吸衰竭,并接受清醒俯卧位治疗。记录俯卧位的持续时间、频率、耐受性和不良事件。在俯卧位前后评估呼吸参数。主要结局是俯卧位的耐受性和安全性。
2020 年 4 月至 5 月期间,共纳入 17 例患者(12 例 ICU,5 例医院病房)。俯卧位天数的中位数(范围)为 1 天(1-7 天),每日俯卧位次数的中位数为 2 次(1-6 次)。俯卧位持续时间为 75 分钟(30-480 分钟),仰卧位时外周血氧饱和度为 91%(84-95),俯卧位时为 98%(92-100)。俯卧位持续时间受限的原因是疼痛/全身不适(47%)和意识障碍(6%);47%的患者没有受限。7 例(41%)患者需要插管,2 例(12%)患者死亡。
在小样本中,对严重低氧血症的非插管 COVID-19 患者进行俯卧位治疗是安全的;然而,许多患者无法耐受长时间的俯卧位。尽管患者在俯卧位时氧合和呼吸频率得到改善,但许多患者仍需要插管。需要进一步的研究来确定提高清醒俯卧位耐受性的方法,以及是否对临床结局有影响。